Wealth Quarterback’s Exact Sciences EXAS Stock Holding History

Wealth Quarterback’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19	Closed	-$3K	–	857
2021 Q2	$3K	Buy	+19	New	+$2.27K	﹤0.01%	687

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wealth Quarterback's EXAS Position: Q3 2021 in Review

Wealth Quarterback sold out of Exact Sciences (EXAS) in Q3 2021, closing a stake of 19 shares — an estimated $3K sold.

Wealth Quarterback first reported a position in EXAS in Q2 2021 and held it in 1 quarter. The position peaked at $3K in Q2 2021. 602 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

Wealth Quarterback reported no remaining Exact Sciences position as of Q3 2021 after selling out during the quarter.
Wealth Quarterback sold 19 Exact Sciences shares in Q3 2021, an estimated $3K.
Wealth Quarterback first reported a position in Exact Sciences in Q2 2021 and held it in 1 quarter.
Wealth Quarterback's Exact Sciences position peaked at $3K in Q2 2021.
602 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.